Hansruedi Loetscher

Title: Innovations of Hansruedi Loetscher

Introduction

Hansruedi Loetscher is a notable inventor based in Möhlin, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of antibody molecules. With a total of 5 patents to his name, his work has implications for both pharmaceutical and diagnostic applications.

Latest Patents

One of Hansruedi Loetscher's latest patents focuses on antibodies against amyloid beta 4 with glycosylation in the variable region. This invention relates to a purified antibody molecule preparation characterized by at least one antigen binding site that includes a glycosylated asparagine (Asn) in the variable region of the heavy chain (V). The patent details pharmaceutical and diagnostic compositions that utilize this antibody molecule, which can specifically recognize the β-A4 peptide/Aβ4. The invention also discusses mixtures of antibodies that contain glycosylated antigen binding sites, which may be used in the pharmaceutical intervention of amyloidogenesis or amyloid-plaque formation, as well as in diagnostic applications.

Career Highlights

Throughout his career, Hansruedi Loetscher has worked with prominent companies in the biotechnology sector, including F. Hoffmann-La Roche AG and MorphoSys AG. His experience in these organizations has contributed to his expertise in antibody development and related technologies.

Collaborations

Some of his notable coworkers include Bernd Bohrmann and Manfred Brockhaus. Their collaboration has likely enhanced the innovative processes and research outcomes in their respective fields.

Conclusion

Hansruedi Loetscher's contributions to the field of biotechnology, particularly through his patented innovations, have the potential to advance both therapeutic and diagnostic methodologies. His work exemplifies the importance of innovation in addressing complex medical challenges.